TP53 and LacZ Mutagenesis Induced by 3-nitrobenzanthrone in Xpa-deficient Human TP53 Knock-in Mouse Embryo Fibroblasts
Overview
Molecular Biology
Authors
Affiliations
3-Nitrobenzanthrone (3-NBA) is a highly mutagenic compound and possible human carcinogen found in diesel exhaust. 3-NBA forms bulky DNA adducts following metabolic activation and induces predominantly G:CT:A transversions in a variety of experimental systems. Here we investigated the influence of nucleotide excision repair (NER) on 3-NBA-induced mutagenesis of the human tumour suppressor gene TP53 and the reporter gene lacZ. To this end we utilised Xpa -knockout (Xpa-Null) human TP53 knock-in (Hupki) embryo fibroblasts (HUFs). As Xpa is essential for NER of bulky DNA adducts, we hypothesized that DNA adducts induced by 3-NBA would persist in the genomes of Xpa-Null cells and lead to an increased frequency of mutation. The HUF immortalisation assay was used to select for cells harbouring TP53 mutations following mutagen exposure. We found that Xpa-Null Hupki mice and HUFs were more sensitive to 3-NBA treatment than their wild-type (Xpa-WT) counterparts. However, following 3-NBA treatment and immortalisation, a similar frequency of TP53-mutant clones arose from Xpa-WT and Xpa-Null HUF cultures. In cells from both Xpa genotypes G:CT:A transversion was the predominant TP53 mutation type and mutations exhibited bias towards the non-transcribed strand. Thirty-two percent of 3-NBA-induced TP53 mutations occurred at CpG sites, all of which are hotspots for mutation in smokers' lung cancer (codons 157, 158, 175, 245, 248, 273, 282). We also examined 3-NBA-induced mutagenesis of an integrated lacZ reporter gene in HUFs, where we again observed a similar mutant frequency in Xpa-WT and Xpa-Null cells. Our findings suggest that 3-NBA-DNA adducts may evade removal by global genomic NER; the persistence of 3-NBA adducts in DNA may be an important factor in its mutagenicity.
Holzl-Armstrong L, Kucab J, Korenjak M, Luijten M, Phillips D, Zavadil J Methods Protoc. 2019; 2(4).
PMID: 31766274 PMC: 6961128. DOI: 10.3390/mps2040085.
Phi K, Smith M, Tokarsky E, Suo Z Chem Res Toxicol. 2019; 32(8):1699-1706.
PMID: 31286773 PMC: 7198833. DOI: 10.1021/acs.chemrestox.9b00219.
Murray J, Mesaros C, Arlt V, Seidel A, Blair I, Penning T Chem Res Toxicol. 2018; 31(11):1277-1288.
PMID: 30406992 PMC: 6319660. DOI: 10.1021/acs.chemrestox.8b00250.
Wohak L, Baranski A, Krais A, Schmeiser H, Phillips D, Arlt V Mutagenesis. 2018; 33(4):311-321.
PMID: 30215795 PMC: 6180618. DOI: 10.1093/mutage/gey025.
Long A, Wills J, Krolak D, Guo M, Dertinger S, Arlt V Arch Toxicol. 2017; 92(2):967-982.
PMID: 29177888 PMC: 5818629. DOI: 10.1007/s00204-017-2099-2.